C4 Therapeutics, Inc. (CCCC)
2.16
+0.04
(+1.89%)
USD |
NASDAQ |
Feb 20, 16:00
2.16
0.00 (0.00%)
After-Hours: 20:00
C4 Therapeutics EPS Diluted (Quarterly) : -0.4433 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Biogen, Inc. | -0.3333 |
| Pfizer Inc. | -0.2898 |
| ACADIA Pharmaceuticals, Inc. | 0.4206 |
| Agenus, Inc. | 1.944 |
| Alnylam Pharmaceuticals, Inc. | 1.368 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -32.17M |
| Revenue (Quarterly) | 11.23M |
| Total Expenses (Quarterly) | 43.40M |
| Enterprise Value | 75.04M |
| Gross Profit Margin (Quarterly) | 81.55% |
| Profit Margin (Quarterly) | -286.4% |
| Earnings Yield | -77.36% |
| Normalized Earnings Yield | -72.57 |